gonadotropin-releasing hormone analogue

A gonadotropin-releasing hormone analogue puts your body into a state like menopause for as long as you take it.

Gonadotropin-releasing hormone analogues.

Gonadotropin-releasing hormone analogues, which last longer and have fewer side-effects, are also effective in reducing libido and may be used.

Young women may be treated with either gonadotropin-releasing hormone analogues (GnRH-As) 1 to 3 months before the procedure.

However, there have been attempts using gonadotropin-releasing hormone analogue (GnRH-A) to induce spawning.

Gonadotropin-releasing hormone analogues (GnRH-As) are rarely used now.

Before myomectomy, shrinking fibroids with gonadotropin-releasing hormone analogue (GnRH-a) therapy may reduce blood loss from the surgery.

Confirm a diagnosis before the start of treatment with medicines that have significant side effects, such as danazol or a gonadotropin-releasing hormone analogue (GnRH-a).

Gonadotropin-releasing hormone analogue (GnRH-a) therapy is approved for the treatment of endometriosis and uterine fibroids.

If you are considering gonadotropin-releasing hormone analogue (GnRH-a) therapy for uterine fibroids, think about the following when making your decision:

Gonadotropin-releasing hormone analogue (GnRH-a) therapy puts the body in a state like menopause, which shrinks the uterus and fibroids.

Rarely used medicines that stop your body from making estrogen and having menstrual periods, such as gonadotropin-releasing hormone analogues (GnRH-As).

But in some severe or urgent cases, estrogen may be used to reduce bleeding.1 Hormone suppressors such as gonadotropin-releasing hormone analogues (GnRH-As).

This is generally done using one of two similar types of gonadotropin-releasing hormone analogue (GnRH agonist or GnRH antagonist).

Gonadotropin-releasing hormone analogues, often used to treat endometriosis, an overgrowth of uterine tissue, have also been associated with bone loss, particularly in those with low bone mass to start with.

Treatment may consist of surgery in the case of tumors, lower doses of estrogen in the case of exogenously-mediated estrogen excess, and estrogen-suppressing medications like gonadotropin-releasing hormone analogues and progestogens.

Those medications include ketoconazole, cimetidine, gonadotropin-releasing hormone analogues, human growth hormone, human chorionic gonadotropin, antiandrogens such as bicalutamide, flutamide, and spironolactone, and 5-alpha-reductase inhibitors such as finasteride or dutasteride.